ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
TransCode Therapeutics Inc

TransCode Therapeutics Inc (RNAZ)

0,3109
0,0109
(3,63%)
Geschlossen 23 April 10:00PM
0,3245
0,0136
( 4,37% )
Vor Marktöffnung: 2:19PM

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
0,3245
Gebot
0,3165
Fragen
0,3267
Volumen
36.199
0,00 Tagesbereich 0,00
0,219565 52-Wochen-Bereich 66,33
Marktkapitalisierung
Handelsende
0,3109
Handelsbeginn
-
Letzter Handelszeitpunkt
14:19:01
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
7.212.799
Ausgegebene Aktien
23.341.336
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,39
Gewinn pro Aktie (EPS)
-0,79
Erlöse
-
Nettogewinn
-18,55M

Über TransCode Therapeutics Inc

TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regre... TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics. The company's lead therapeutic candidate, TTX-MC138, is focused on treating metastatic cancer, which has the potential to produce regression without recurrence in a range of cancers, including breast, pancreatic, ovarian and colon cancer, glioblastomas and others. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Hauptsitz
Wilmington, Delaware, USA
Gegründet
-
TransCode Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RNAZ. The last closing price for TransCode Therapeutics was US$0,31. Over the last year, TransCode Therapeutics shares have traded in a share price range of US$ 0,219565 to US$ 66,33.

TransCode Therapeutics currently has 23.341.336 shares in issue. The market capitalisation of TransCode Therapeutics is US$7,26 million. TransCode Therapeutics has a price to earnings ratio (PE ratio) of -0.39.

RNAZ Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-0.0665-17.00767263430.3910.3950.21956559105800.30028835CS
4-0.3305-50.45801526720.6550.670.21956548142360.44052213CS
12-8.8155-96.44967177249.1414.24990.21956572127991.69668456CS
26-20.4655-98.439153439220.7925.410.21956539944282.98968474CS
52-14.8225-97.857661583215.14766.330.21956528426868.63977047CS
156-65999.6755-99.999508333366000784080.21956521490844771.88775858CS
260-158399.6755-99.99979513891584001848000.219565201686020959.5759105CS

RNAZ - Frequently Asked Questions (FAQ)

What is the current TransCode Therapeutics share price?
The current share price of TransCode Therapeutics is US$ 0,3245
How many TransCode Therapeutics shares are in issue?
TransCode Therapeutics has 23.341.336 shares in issue
What is the market cap of TransCode Therapeutics?
The market capitalisation of TransCode Therapeutics is USD 7,26M
What is the 1 year trading range for TransCode Therapeutics share price?
TransCode Therapeutics has traded in the range of US$ 0,219565 to US$ 66,33 during the past year
What is the PE ratio of TransCode Therapeutics?
The price to earnings ratio of TransCode Therapeutics is -0,39
What is the reporting currency for TransCode Therapeutics?
TransCode Therapeutics reports financial results in USD
What is the latest annual profit for TransCode Therapeutics?
The latest annual profit of TransCode Therapeutics is USD -18,55M
What is the registered address of TransCode Therapeutics?
The registered address for TransCode Therapeutics is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the TransCode Therapeutics website address?
The website address for TransCode Therapeutics is www.transcodetherapeutics.com
Which industry sector does TransCode Therapeutics operate in?
TransCode Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
ENSCEnsysce Biosciences Inc
US$ 4,47
(139,04%)
9,63M
AGMHAGM Group Holdings Inc
US$ 0,0709
(136,33%)
222,44M
SNOASonoma Pharmaceuticals Inc
US$ 4,22
(81,12%)
33,26M
DSGNDesign Therapeutics Inc
US$ 6,09
(53,79%)
81
FUSBFirst US Bancshares Inc
US$ 19,00
(51,52%)
1
FORAForian Inc
US$ 1,06
(-45,08%)
3
TBLDThomburg Income Builder Opportunities Trust
US$ 10,01
(-42,90%)
294
FONRFonar Corporation
US$ 9,01
(-25,38%)
5
MRINMarin Software Incorporated
US$ 0,6199
(-24,92%)
88,52k
BSCVInvesco BulletShares 2031 Corporate Bond ETF
US$ 12,11
(-24,74%)
2
AGMHAGM Group Holdings Inc
US$ 0,0709
(136,33%)
222,44M
BTOGBit Origin Ltd
US$ 0,186899
(42,35%)
82,07M
DMNDamon Inc
US$ 0,00395
(1,28%)
47,39M
SNOASonoma Pharmaceuticals Inc
US$ 4,22
(81,12%)
33,26M
AGRIAgriFORCE Growing Systems Ltd
US$ 1,94
(34,39%)
29,02M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock